查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1482392

生物材料市場：依產品類型、最終用戶、地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2032 年

Biomaterials Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究徹底分析了生物材料市場，並提供了詳細介紹其全球前景的綜合報告。 這份詳細的出版物提供了有關市場動態、趨勢、機會和課題的寶貴見解，並對其結構進行了全面概述。 在獨特的數據和統計數據的支持下，本研究預測了 2024 年至 2032 年生物材料市場的預期成長軌跡。

2024年，全球生物材料市場價值1468.3億美元。 預計到 2032 年將激增至 4,700 億美元，2024 年至 2032 年複合年增長率為 14.5%。

關鍵見解

  • 生物材料市場規模（2024 年）：1,468.3 億美元
  • 預測市場規模（2032 年）：4,700 億美元
  • 全球市場成長率（複合年增長率，2024-2032 年）：14.5%

生物材料市場 - 報告範圍：

生物材料是各種醫療應用的基本組成部分，包括植入物、義肢、組織工程、藥物傳遞系統和再生醫學。 該市場面向醫療保健產業、研究機構和學術中心，提供各種生物材料，包括金屬、陶瓷、聚合物和複合材料。

市場成長是由慢性病盛行率上升、人口老化、材料科學技術進步以及對微創外科手術需求不斷增加等因素所推動的。 此外，生物材料在骨科、心血管外科、牙科和眼科手術中的不斷擴大的應用正在推動市場擴張，並促進生物材料製造商、醫療器材製造商和醫療保健提供者之間的合作。

推動市場成長的因素：

醫療植入物的需求不斷增加：骨科、心血管和牙科疾病的日益流行正在增加對基於生物材料的醫療植入物（例如人工關節、支架、牙科植入物和起搏器）的需求，這增加了需求並支持市場成長。

技術創新：生物材料合成、表面改質技術和積層製造技術的進步使得生物相容性、生物可吸收性和功能性生物材料的開發成為可能，從而改善植入物的性能和患者的治療效果。

在再生醫學中的應用：生物材料在組織工程、幹細胞治療、器官移植等方面發揮著重要作用，促進組織再生、傷口癒合和功能恢復，拓展了再生醫學和細胞治療領域的市場。擴展。

市場限制因素：

生物相容性和免疫原性：植入物與宿主的相互作用、異物反應和長期生物降解特性因生物材料的類型和應用而異；確保安全仍然是一個課題。

監管合規性：生物材料分類、安全評估和臨床測試方面的監管障礙給製造商帶來了合規負擔，並影響了上市障礙、產品開發時間表和商業化策略。

成本和承受能力：生物材料製造、品質控制流程和監管批准的成本高昂，特別是在新興市場，使用先進生物材料進行治療的醫療預算和報銷範圍有限，這對廣泛使用造成了經濟障礙。

市場機會：

個人化醫療：個人化醫療和精準醫療模式的出現正在促進患者特異性生物材料、客製化植入物和能夠適應臨床變異的標靶藥物輸送系統的開發。

多功能生物材料：將生物材料與生物活性分子、生長因子和治療劑結合，可生產多功能植入物、智慧型裝置和控釋製劑，以提高治療效果和降低醫療成本。

生物製造技術：3D生物列印、組織工程和晶片器官平台的進步促進了複雜仿生結構、血管組織和類器官的創建，以加速藥物發現、疾病建模和個人化再生治療。

本報告解決的關鍵問題

  • 推動全球生物材料市場成長的關鍵因素有哪些？
  • 哪些類型和應用的生物材料正在推動各個醫療保健領域的市場推廣？
  • 技術進步如何改變生物材料市場的競爭格局？
  • 誰是生物材料市場的主要參與者？
  • 全球生物材料市場的新趨勢和未來前景是什麼？

競爭資訊與業務策略：

全球生物材料市場的領先公司正在專注於創新、產品差異化和策略合作夥伴關係，以獲得競爭優勢。 這些公司投資於研發，開發先進的生物材料配方、製造流程和生物醫學設備，以滿足各種臨床需求和治療應用。 與醫療保健提供者、學術機構和監管機構的合作夥伴關係促進市場進入和技術採用，促進市場成長和擴張。

主要公司簡介

  • Evonik Industries AG
  • Medtronic plc
  • Carpenter Technology Corporation
  • Invibio Ltd.
  • Berkeley Advanced Biomaterials
  • BASF SE
  • Zimmer Biomet Holdings, Inc.
  • Stryker
  • Covalon Technologies Ltd.
  • Johnson & Johnson

生物材料產業研究細分

依材質

  • 金屬生物材料
  • 陶瓷生物材料
  • 高分子生物材料
  • 天然生物材料

依目的

  • 牙科
  • 心血管
  • 骨科
  • 傷口癒合
  • 神經病學
  • 手術

依地區

  • 北美
  • 拉丁美洲
  • 歐洲
  • 南亞
  • 東亞
  • 大洋洲
  • 中東/非洲

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 價值鏈分析
  • 波特五力分析
  • 杵分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 經濟概況
  • 法規和認證

第三章宏觀經濟與預測因子

  • 世界經濟成長展望
  • GDP 成長前景
  • 依行業劃分的世界成長前景
  • 其他宏觀經濟因素

第 4 章 2024-2032 年全球生物材料市場展望

  • 全球生物材料市場前景：依材料種類、數量、價值劃分，2024-2032 年
    • 主要亮點
      • 金屬生物材料
      • 陶瓷生物材料
      • 高分子生物材料
      • 天然生物材料
  • 全球生物材料市場前景：依應用、數量、價值劃分，2024-2032 年
    • 主要亮點
      • 牙科
      • 心血管
      • 骨科
      • 傷口癒合
      • 神經病學
      • 手術
  • 全球生物材料市場展望：地區、數量、價值，2024-2032 年
    • 主要亮點
      • 北美
      • 歐洲
      • 東亞
      • 南亞/大洋洲
      • 拉丁美洲
      • 中東/非洲

第五章北美生物材料市場展望，2024-2032

第 6 章歐洲生物材料市場展望，2024-2032

第 7 章南亞/大洋洲生物材料市場前景，2024-2032

第 8 章東亞生物材料市場展望，2024-2032

第 9 章拉丁美洲生物材料市場前景，2024-2032

第 10 章 2024-2032 年中東及非洲生物材料市場前景

第十一章競爭態勢

  • 材料類型與應用熱圖
  • 製造商與材料類型熱圖
  • 2023 年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • Evonik Industries AG
    • Medtronic plc
    • Carpenter Technology Corporation
    • Invibio Ltd.
    • Berkeley Advanced Biomaterials
    • BASF SE
    • Covestro AG
    • Celanese Corporation
    • Zimmer Biomet Holdings, Inc.
    • Stryker
    • Covalon Technologies Ltd.
    • Johnson & Johnson
    • DSM Netherlands
    • Corbion NV
    • Victrex Plc
    • Mitsubishi Chemical Group Corporation

第12章附錄

  • 調查方法
  • 報告先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP2781

Persistence Market Research has conducted a thorough analysis of the Biomaterials Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Biomaterials Market spanning from 2024 to 2032.

In 2024, the global biomaterials market reached a valuation of US$ 146.83 billion. By 2032, it is projected to soar to US$ 470 billion, experiencing a substantial CAGR of 14.5% from 2024 to 2032.

Key Insights:

  • Biomaterials Market Size (2024): US$ 146.83 billion
  • Projected Market Value (2032): US$ 470 billion
  • Global Market Growth Rate (CAGR 2024-2032): 14.5%

Biomaterials Market - Report Scope:

Biomaterials serve as fundamental components in various medical applications, including implants, prosthetics, tissue engineering, drug delivery systems, and regenerative medicine. The market caters to healthcare industries, research institutions, and academic centers, offering a diverse range of biomaterial types, including metals, ceramics, polymers, and composites.

Market growth is propelled by factors such as increasing prevalence of chronic diseases, aging population, technological advancements in material science, and growing demand for minimally invasive surgical procedures. Moreover, the expanding application of biomaterials in orthopedics, cardiovascular, dental, and ophthalmic surgeries fosters market expansion, driving collaborations between biomaterial manufacturers, medical device companies, and healthcare providers.

Market Growth Drivers:

Rising Demand for Medical Implants: The growing prevalence of orthopedic disorders, cardiovascular diseases, and dental conditions drives the demand for biomaterial-based medical implants, including joint replacements, stents, dental implants, and pacemakers, supporting market growth.

Technological Innovations: Advances in biomaterial synthesis, surface modification techniques, and additive manufacturing technologies enable the development of biocompatible, bioresorbable, and functional biomaterials, enhancing implant performance and patient outcomes.

Regenerative Medicine Applications: Biomaterials play a critical role in tissue engineering, stem cell therapy, and organ transplantation, facilitating tissue regeneration, wound healing, and functional restoration, driving market expansion in regenerative medicine and cell therapy fields.

Market Restraints:

Biocompatibility and Immunogenicity: Ensuring biomaterial biocompatibility, bioactivity, and immunological safety remains a challenge, as implant-host interactions, foreign body responses, and long-term biodegradation properties vary among different biomaterial types and applications.

Regulatory Compliance: Regulatory hurdles related to biomaterial classification, safety assessment, and clinical testing impose compliance burdens on manufacturers, affecting market entry barriers, product development timelines, and commercialization strategies.

Cost and Affordability: The high cost of biomaterial manufacturing, quality control processes, and regulatory approvals pose economic barriers to widespread adoption, particularly in emerging markets with limited healthcare budgets and reimbursement coverage for advanced biomaterial-based therapies.

Market Opportunities:

Personalized Medicine: The advent of personalized medicine and precision healthcare models promotes the development of patient-specific biomaterials, customized implants, and targeted drug delivery systems, addressing individual genetic, physiological, and clinical variability.

Multifunctional Biomaterials: Integration of biomaterials with bioactive molecules, growth factors, and therapeutic agents enables the fabrication of multifunctional implants, smart devices, and controlled-release formulations, enhancing therapeutic efficacy and reducing healthcare costs.

Biofabrication Technologies: Advancements in 3D bioprinting, tissue engineering, and organ-on-a-chip platforms facilitate the fabrication of complex biomimetic structures, vascularized tissues, and organoids, accelerating drug discovery, disease modeling, and personalized regenerative therapies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global biomaterials market?
  • Which biomaterial types and applications are driving market adoption across different healthcare sectors?
  • How are technological advancements reshaping the competitive landscape of the biomaterials market?
  • Who are the key players contributing to the biomaterials market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global biomaterials market?

Competitive Intelligence and Business Strategy:

Leading players in the global biomaterials market focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced biomaterial formulations, manufacturing processes, and biomedical devices, catering to diverse clinical needs and therapeutic applications. Collaborations with healthcare providers, academic institutions, and regulatory agencies facilitate market access and technology adoption, driving market growth and expansion.

Key Companies Profiled

  • Evonik Industries AG
  • Medtronic plc
  • Carpenter Technology Corporation
  • Invibio Ltd.
  • Berkeley Advanced Biomaterials
  • BASF SE
  • Zimmer Biomet Holdings, Inc.
  • Stryker
  • Covalon Technologies Ltd.
  • Johnson & Johnson

Biomaterials Industry Research Segmentation

By Material:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

By Application:

  • Dental
  • Cardiovascular
  • Orthopedic
  • Wound Healing
  • Neurology
  • Surgery

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa"

Table of Contents

1. Executive Summary

  • 1.1. Global Biomaterials Market Snapshot, 2023 and 2031
  • 1.2. Market Opportunity Assessment, 2024-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. PESTLE Analysis
  • 2.6. COVID-19 Impact Analysis
  • 2.7. Economic Overview
  • 2.8. Regulations and Certifications

3. Macro-economic and Forecast Factors

  • 3.1. Global Economic Growth Outlook
  • 3.2. GDP Growth Outlook
  • 3.3. Global Sectoral Growth Outlook
  • 3.4. Other Macroeconomic Factors

4. Global Biomaterials Market Outlook, 2024-2032

  • 4.1. Global Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Metallic Biomaterials
      • 4.1.1.2. Ceramic Biomaterials
      • 4.1.1.3. Polymeric Biomaterials
      • 4.1.1.4. Natural Biomaterials
  • 4.2. Global Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dental
      • 4.2.1.2. Cardiovascular
      • 4.2.1.3. Orthopaedic
      • 4.2.1.4. Wound Healing
      • 4.2.1.5. Neurology
      • 4.2.1.6. Surgery
  • 4.3. Global Biomaterials Market Outlook, by Region, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. North America
      • 4.3.1.2. Europe
      • 4.3.1.3. East Asia
      • 4.3.1.4. South Asia & Oceania
      • 4.3.1.5. Latin America
      • 4.3.1.6. Middle East & Africa

5. North America Biomaterials Market Outlook, 2024-2032

  • 5.1. North America Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Metallic Biomaterials
      • 5.1.1.2. Ceramic Biomaterials
      • 5.1.1.3. Polymeric Biomaterials
      • 5.1.1.4. Natural Biomaterials
  • 5.2. North America Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dental
      • 5.2.1.2. Cardiovascular
      • 5.2.1.3. Orthopaedic
      • 5.2.1.4. Wound Healing
      • 5.2.1.5. Neurology
      • 5.2.1.6. Surgery
  • 5.3. North America Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Biomaterials Market Outlook, 2024-2032

  • 6.1. Europe Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Metallic Biomaterials
      • 6.1.1.2. Ceramic Biomaterials
      • 6.1.1.3. Polymeric Biomaterials
      • 6.1.1.4. Natural Biomaterials
  • 6.2. Europe Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dental
      • 6.2.1.2. Cardiovascular
      • 6.2.1.3. Orthopaedic
      • 6.2.1.4. Wound Healing
      • 6.2.1.5. Neurology
      • 6.2.1.6. Surgery
  • 6.3. Europe Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Germany
      • 6.3.1.2. Italy
      • 6.3.1.3. France
      • 6.3.1.4. U.K.
      • 6.3.1.5. Spain
      • 6.3.1.6. Russia
      • 6.3.1.7. Rest of Europe
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. South Asia & Oceania Biomaterials Market Outlook, 2024-2032

  • 7.1. South Asia & Oceania Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Metallic Biomaterials
      • 7.1.1.2. Ceramic Biomaterials
      • 7.1.1.3. Polymeric Biomaterials
      • 7.1.1.4. Natural Biomaterials
  • 7.2. South Asia & Oceania Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dental
      • 7.2.1.2. Cardiovascular
      • 7.2.1.3. Orthopaedic
      • 7.2.1.4. Wound Healing
      • 7.2.1.5. Neurology
      • 7.2.1.6. Surgery
  • 7.3. South Asia & Oceania Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. India
      • 7.3.1.2. Southeast
      • 7.3.1.3. ANZ
      • 7.3.1.4. Rest of South Asia & Oceania
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. East Asia Biomaterials Market Outlook, 2024-2032

  • 8.1. East Asia Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Metallic Biomaterials
      • 8.1.1.2. Ceramic Biomaterials
      • 8.1.1.3. Polymeric Biomaterials
      • 8.1.1.4. Natural Biomaterials
  • 8.2. East Asia Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dental
      • 8.2.1.2. Cardiovascular
      • 8.2.1.3. Orthopaedic
      • 8.2.1.4. Wound Healing
      • 8.2.1.5. Neurology
      • 8.2.1.6. Surgery
  • 8.3. East Asia Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. China
      • 8.3.1.2. Japan
      • 8.3.1.3. South Korea
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Biomaterials Market Outlook, 2024-2032

  • 9.1. Latin America Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Metallic Biomaterials
      • 9.1.1.2. Ceramic Biomaterials
      • 9.1.1.3. Polymeric Biomaterials
      • 9.1.1.4. Natural Biomaterials
  • 9.2. Latin America Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Dental
      • 9.2.1.2. Cardiovascular
      • 9.2.1.3. Orthopaedic
      • 9.2.1.4. Wound Healing
      • 9.2.1.5. Neurology
      • 9.2.1.6. Surgery
  • 9.3. Latin America Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Brazil
      • 9.3.1.2. Mexico
      • 9.3.1.3. Rest of Latin America
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Biomaterials Market Outlook, 2024-2032

  • 10.1. Middle East & Africa Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 10.1.1. Key Highlights
      • 10.1.1.1. Metallic Biomaterials
      • 10.1.1.2. Ceramic Biomaterials
      • 10.1.1.3. Polymeric Biomaterials
      • 10.1.1.4. Natural Biomaterials
  • 10.2. Middle East & Africa Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 10.2.1. Key Highlights
      • 10.2.1.1. Dental
      • 10.2.1.2. Cardiovascular
      • 10.2.1.3. Orthopaedic
      • 10.2.1.4. Wound Healing
      • 10.2.1.5. Neurology
      • 10.2.1.6. Surgery
  • 10.3. Middle East & Africa Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 10.3.1. Key Highlights
      • 10.3.1.1. GCC
      • 10.3.1.2. South Africa
      • 10.3.1.3. Turkiye
      • 10.3.1.4. Rest of Middle East and Africa

11. Competitive Landscape

  • 11.1. Material Type vs Application Heatmap
  • 11.2. Manufacturer vs Material Type Heatmap
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Evonik Industries AG
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Medtronic plc
    • 11.5.3. Carpenter Technology Corporation
    • 11.5.4. Invibio Ltd.
    • 11.5.5. Berkeley Advanced Biomaterials
    • 11.5.6. BASF SE
    • 11.5.7. Covestro AG
    • 11.5.8. Celanese Corporation
    • 11.5.9. Zimmer Biomet Holdings, Inc.
    • 11.5.10. Stryker
    • 11.5.11. Covalon Technologies Ltd.
    • 11.5.12. Johnson & Johnson
    • 11.5.13. DSM Netherlands
    • 11.5.14. Corbion NV
    • 11.5.15. Victrex Plc
    • 11.5.16. Mitsubishi Chemical Group Corporation

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations